All lobbying filings

VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC)

Lobbying for CLINICAL REFERENCE LABORATORY, INC. · privately held clinical testing laboratory

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 18, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Kansas

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Policies and regulations impacting clinical laboratories and drug testing, including issues related to HHS and DOT; H.R.4320, Drug and Alcohol Clearinghouse Public Safety Improvement Act of 2025; DOT Rule 49 CFR Part 40 Section 40.82.

Bills named in this filing 1

H.R. 4320
Drug and Alcohol Clearinghouse Public Safety Improvement Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.